These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24434592)
1. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. Cao H; Zhu J; Xi L; Røe OD; Chen Y; Wang D Cardiology; 2014; 127(3):183-9. PubMed ID: 24434592 [TBL] [Abstract][Full Text] [Related]
2. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. Xi L; Cao H; Zhu J; Røe OD; Li M; Wu Y; Wang D; Chen Y Cardiology; 2013; 124(1):18-24. PubMed ID: 23295350 [TBL] [Abstract][Full Text] [Related]
3. Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation. Cao H; Wu Y; Li Q; Wu Y; Zhou Q; Røe OD; Chen Y; Wang R; Wang D Int J Cardiol; 2014 Jan; 170(3):298-302. PubMed ID: 24326209 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. Cao H; Zhou Q; Wu Y; Li Q; Røe OD; Chen Y; Wu Z; Wang D Ann Thorac Surg; 2013 Sep; 96(3):800-6. PubMed ID: 23870696 [TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. Cao H; Li Q; Li M; Od R; Wu Z; Zhou Q; Cao B; Chen B; Chen Y; Wang D Int J Cardiol; 2013 Jul; 166(3):702-8. PubMed ID: 22178057 [TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: Effects of the cryo-maze procedure and predictors for late recurrence. Baek MJ; Na CY; Oh SS; Lee CH; Kim JH; Seo HJ; Park SW; Kim WS Eur J Cardiothorac Surg; 2006 Nov; 30(5):728-36. PubMed ID: 17008109 [TBL] [Abstract][Full Text] [Related]
10. Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. Cao H; Wang J; Xi L; Røe OD; Chen Y; Wang D Circ J; 2011; 75(12):2781-8. PubMed ID: 22001292 [TBL] [Abstract][Full Text] [Related]
11. Superior left atrial approach to the mitral valve: incidence of postoperative arrhythmia. Bergmann P; Huber S; Hödl R; Mächler H; Oberwalder P; Martin D; Rigler B J Heart Valve Dis; 2005 Jan; 14(1):130-6. PubMed ID: 15700447 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of cryoablation with a new cryoprobe to eliminate chronic atrial fibrillation associated with mitral valve disease. Tada H; Ito S; Naito S; Hasegawa Y; Kurosaki K; Ezure M; Kaneko T; Oshima S; Taniguchi K; Nogami A Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S73-7. PubMed ID: 15683531 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Franchimont N; Reenaers C; Lambert C; Belaiche J; Bours V; Malaise M; Delvenne P; Louis E Clin Exp Immunol; 2004 Dec; 138(3):491-8. PubMed ID: 15544627 [TBL] [Abstract][Full Text] [Related]
14. Catheter ablation of complex left atrial arrhythmias in patients after percutaneous or surgical mitral valve procedures. Derejko P; Walczak F; Chmielak Z; Romanowska I; Wójcik A; Bilińska M; Hryniewiecki T; Rużyłło W; Szumowski Ł Kardiol Pol; 2013; 71(8):818-26. PubMed ID: 24049021 [TBL] [Abstract][Full Text] [Related]
15. Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience. Kim KC; Cho KR; Kim YJ; Sohn DW; Kim KB Eur J Cardiothorac Surg; 2007 Feb; 31(2):261-6. PubMed ID: 17158057 [TBL] [Abstract][Full Text] [Related]
16. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients. Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829 [TBL] [Abstract][Full Text] [Related]
17. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM Menopause; 2008; 15(2):357-62. PubMed ID: 17925661 [TBL] [Abstract][Full Text] [Related]
18. Long-term results and reliability of cryothermic ablation based maze procedure for atrial fibrillation concomitant with mitral valve surgery. Funatsu T; Kobayashi J; Nakajima H; Iba Y; Shimahara Y; Yagihara T Eur J Cardiothorac Surg; 2009 Aug; 36(2):267-71; discussion 271. PubMed ID: 19414270 [TBL] [Abstract][Full Text] [Related]
19. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326 [TBL] [Abstract][Full Text] [Related]
20. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]